RADX - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 90226491
Serial Number
90226491
Registration Number
6534475
Word Mark
RADX
Status
700 - Registered
Status Date
2021-10-26
Filing Date
2020-09-30
Registration Number
6534475
Registration Date
2021-10-26
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2021-08-10
Attorney Name
Angela Y. Dai
Law Office Assigned Location Code
O30
Employee Name
BAKER, JORDAN A
Statements
Goods and Services
Promoting research, development, validation, commercialization, and implementation of testing technologies for pathogens; promoting research, development, validation, commercialization, and implementation of testing technologies for viruses; promoting research, development, validation, commercialization, and implementation of testing technologies for viruses that cause COVID-19 and influenza flu; promoting improvement of clinical laboratory testing technologies for COVID-19 and influenza flu; promoting research, development, validation, commercialization, and implementation of testing technologies for pathogens through support of scientific organizations, research institutions, medical institutions, academic institutions, non-profit organizations, and business entities; promoting research, development, validation, commercialization, and implementation of testing technologies for viruses that cause COVID-19 and influenza flu through support of scientific organizations, research institutions, medical institutions, academic institutions, non-profit organizations, and business entities; promoting collaboration within the scientific, research, medical, academic, and business communities to advance research, development, commercialization, and implementation of testing technologies for pathogens; promoting collaboration within the scientific, research, medical, academic, and business communities to advance research, development, commercialization, and implementation of testing technologies for viruses that cause COVID-19 and influenza flu; promoting collaboration within the technology innovator, clinical testing, regulatory affairs, entrepreneur, business leader, and community leader networks to advance research, development, commercialization, and implementation of testing technologies for pathogens; promoting collaboration within the technology innovator, clinical testing, regulatory affairs, entrepreneur, business leader, and community leader networks to advance research, development, commercialization, and implementation of testing technologies for viruses that cause COVID-19 and influenza flu; promoting community-engaged projects to assess and expand availability of testing technologies for pathogens in underserved and/or vulnerable populations; promoting community-engaged projects to assess and expand availability of testing technologies for viruses that cause COVID-19 and influenza flu in underserved and/or vulnerable populations; promoting collaboration between the scientific research community and underserved and/or vulnerable populations to achieve increased accessibility and availability of testing technologies for pathogens in underserved and/or vulnerable populations; promoting collaboration between the scientific research community and underserved and/or vulnerable populations to achieve increased accessibility and availability of testing technologies for viruses that cause COVID-19 and influenza flu in underserved and/or vulnerable populations; promoting rapid scale-up of testing technologies for pathogens; promoting rapid scale-up of testing technologies for viruses that cause COVID-19 and influenza flu; promoting increased availability of testing technologies for pathogens; promoting increased availability of testing technologies for viruses that cause COVID-19 and influenza flu; administration and management of research grants; administration of programs for promoting research, development, validation, commercialization, and implementation of testing technologies for pathogens; administration of programs for promoting research, development, validation, commercialization, and implementation of testing technologies for viruses that cause COVID-19 and influenza flu
Goods and Services
Providing grants and financial support for biomedical research and development; providing grants and financial support for biomedical engineering; providing grants and financial support for research, development, validation, commercialization, and implementation of testing technologies for pathogens; providing grants and financial support for research, development, validation, commercialization, and implementation of testing technologies for viruses; providing grants and financial support for research, development, validation, commercialization, and implementation of testing technologies for viruses that cause COVID-19 and influenza flu; providing grants and financial support for community-engaged projects, namely, establishment of clinical research sites and testing centers in underserved and/or vulnerable communities; providing information regarding funding opportunities relating to biomedical and scientific research and developments via a website
Goods and Services
Providing a website featuring blogs, non-downloadable videos, non-downloadable videocasts, and educational presentations in the nature of seminars, forums, and non-downloadable webinars relating to medical, biomedical and scientific research information and distribution of educational materials in connection therewith
Goods and Services
Providing a website featuring medical, biomedical and scientific research information; providing a website featuring news in the field of biomedical and scientific research and developments; providing a website featuring biomedical and scientific research information and developments, namely, dashboards displaying biomedical and scientific research data, information and developments
Classification Information
International Class
035 - Advertising; business management; business administration; office functions. - Advertising; business management; business administration; office functions.
US Class Codes
100, 101, 102
Class Status Code
6 - Active
Class Status Date
2020-11-14
Primary Code
035
First Use Anywhere Date
2020-04-29
First Use In Commerce Date
2020-04-29
International Class
036 - Insurance; financial affairs; monetary affairs; real estate affairs. - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes
100, 101, 102
Class Status Code
6 - Active
Class Status Date
2020-11-14
Primary Code
036
First Use Anywhere Date
2020-05-00
First Use In Commerce Date
2020-05-00
International Class
041 - Education; providing of training; entertainment; sporting and cultural activities. - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes
100, 101, 107
Class Status Code
6 - Active
Class Status Date
2020-11-14
Primary Code
041
First Use Anywhere Date
2020-06-00
First Use In Commerce Date
2020-06-00
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2020-11-14
Primary Code
042
First Use Anywhere Date
2020-06-00
First Use In Commerce Date
2020-06-00
Current Trademark Owners
Party Name
U.S. Department of Health and Human Services
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (agency of the United States government).
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
U.S. Department of Health and Human Services
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (agency of the United States government).
Address
Please log in with your Justia account to see this address.
Party Name
U.S. Department of Health and Human Services
Party Type
20 - Owner at Publication
Legal Entity Type
99 - Other (agency of the United States government).
Address
Please log in with your Justia account to see this address.
Party Name
U.S. Department of Health and Human Services
Party Type
10 - Original Applicant
Legal Entity Type
99 - Other (agency of the United States government).
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Angela Y. Dai
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2020-10-03NEW APPLICATION ENTERED IN TRAM
2020-11-14NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2020-11-16TEAS PETITION TO DIRECTOR RECEIVED
2020-12-17ASSIGNED TO PETITION STAFF
2020-12-18PETITION TO DIRECTOR - GRANTED
2020-12-21ASSIGNED TO EXAMINER
2020-12-21NON-FINAL ACTION WRITTEN
2020-12-21NON-FINAL ACTION E-MAILED
2020-12-21NOTIFICATION OF NON-FINAL ACTION E-MAILED
2021-01-25TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2021-01-25ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2021-01-25TEAS CHANGE OF CORRESPONDENCE RECEIVED
2021-06-21TEAS RESPONSE TO OFFICE ACTION RECEIVED
2021-06-21CORRESPONDENCE RECEIVED IN LAW OFFICE
2021-06-21TEAS/EMAIL CORRESPONDENCE ENTERED
2021-07-08APPROVED FOR PUB - PRINCIPAL REGISTER
2021-07-21NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2021-08-10PUBLISHED FOR OPPOSITION
2021-08-10OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2021-10-26REGISTERED-PRINCIPAL REGISTER